CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.

Koulis, Athanasios; Di Costanzo, Natasha; Mitchell, Catherine; Lade, Stephen; Goode, David; Busuttil, Rita A; Boussioutas, Alex

Koulis, Athanasios; Di Costanzo, Natasha; Mitchell, Catherine; Lade, Stephen; Goode, David; Busuttil, Rita A; Boussioutas, Alex.

Affiliation

Koulis A; Upper Gastrointestinal Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
Di Costanzo N; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
Mitchell C; Upper Gastrointestinal Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
Lade S; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
Goode D; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Busuttil RA; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Boussioutas A; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.

BMC Gastroenterol ; 22(1): 197, 2022 Apr 21.

Article de En | MEDLINE | ID: mdl-35448971

Sujet(s)
Mots clés

Biomarkers; CD10; Das1; Digital quantification; Gastric cancer; Gene expression profiling; Immunohistochemistry; Intestinal metaplasia subtypes; Logistic regression model; Risk of progression

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: États précancéreux / Tumeurs de l'estomac Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: BMC Gastroenterol Sujet du journal: GASTROENTEROLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Australie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google